357 records found.
Dec 09, 2019
Actinium Pharmaceuticals Announces Phase 3 SIERRA Trial Dosimetry Results Support Low Dose Iomab-B for Targeted Lymphodepletion Prior to Adoptive Cell Therapy
Dec 09, 2019
Scientific & Commercial Aspects of Personalized Medicine Markets, 2018-2019 & 2028
Dec 06, 2019
Global Gene Therapy Market Growth, Company Profiles, Clinical trials and Forecasts to 2022 - ReportsnReports
Dec 03, 2019
Novasep Launches oXYgene(TM), a Fully Integrated Offer for Boosting Viral Vector Production
Dec 03, 2019
CASI Pharmaceuticals Announces China NMPA Approval Of CNCT19 (CD19 CAR-T) Clinical Trial Applications
Dec 03, 2019
ASGCT Resources on Blood Cancers and CAR T-Cell Therapy Conclude Patient Education Releases for 2019
Dec 03, 2019
CSafe expands cold chain offerings for the Cell and Gene Therapy market with launch of high-performing AcuTemp Plus Series of temperature-controlled packaging
Dec 02, 2019
Bringing Hope to Spinal Muscular Atrophy (SMA) Patients with the Alcyone Lifesciences ThecaFlex DRx(TM) System Breakthrough Device
Nov 28, 2019
Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market (3rd Edition), 2019-2030 (Focus on AAV, Adenoviral, Lentiviral, Retroviral, Plasmid DNA and Other Vectors)
Nov 25, 2019
Global Gene Therapy Research Report 2019: Market Analysis, Trends, and Forecasts to 2025
Nov 22, 2019
Worldwide Cell & Gene Therapy Market Insights Study, 2019-2024 - Market Set to Surpass a CAGR of 24%, Driven by Favorable Regulatory Support & Special Designations
Nov 21, 2019
BioMarin Submits Marketing Authorization Application to European Medicines Agency for Valoctocogene Roxaparvovec to Treat Severe Hemophilia A
Nov 21, 2019
CODA Biotherapeutics Deepens Gene Therapy Expertise with Industry Veteran, Annahita Keravala, Ph.D., and Key Promotions
Nov 19, 2019
The Conference Forum Announces the Launch of Cell & Gene Therapy Day in NYC
Nov 19, 2019
AskBio Receives "Best Venture Funding" Award from Southeast BIO
Nov 15, 2019
Gracell Announces Five Presentations at the Annual Meeting of American Society of Hematology (ASH)
Nov 13, 2019
The Cell and Gene Therapy Market to Reach Revenues of Over $6.6 billion by 2024 - Market Research by Arizton
Nov 07, 2019
Triple-Gene Announces Completion of Enrollment and Dosing in Phase 1 Trial of INXN-4001, First Multigenic Investigational Therapeutic Candidate for Treatment of Heart Failure
Nov 05, 2019
Lonza Partners with Cryoport and Strengthens its 'Vein-to-vein' Delivery Network in Cell & Gene Therapy
Nov 05, 2019
Dystrogen Therapeutics Announces That Treatment With Dystrophin Expressing Chimeric (DEC) Cells Improves Cardiac Function in Preclinical Duchenne's Study

Pages